Self-expanding devices and methods therefor

Inventors

Eaton, Donald J.Huang, BinAbbate, Anthony J.Zaler, Gail M.Gale, David C.

Assignees

Intersect ENT Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11826494-B2

Patent

Publication Date

2023-11-28

Expiration Date


Abstract

Described here are delivery devices for delivering one or more implants to the body, and methods of using. The delivery devices may deliver implants to a variety of locations within the body, for a number of different uses. In some variations, the delivery devices have a cannula with one or more curved sections. In some variations, a pusher may be used to release one or more implants from the cannula. In some variations, one or more of the released implants may be a self-expanding device. Methods of delivering implants to one or more sinus cavities are also described here.

Core Innovation

The invention relates to a method of treating a patient by delivering a self-supported, wire-like expandable device to an ear region of the patient. The expandable device is configured to expand from a first compressed configuration to a second expanded configuration against tissue. The device includes one or more biodegradable polymer filaments formed into a repeating diamond-shaped pattern and is configured to release a drug.

In the disclosed implementations, drug release is achieved in combination with the biodegradable polymer filaments. The expandable device may include at least one biodegradable polymer filament having a drug-eluting layer, such that the expandable device releases the drug. The drug comprises a therapeutic agent selected from specified categories, including anti-inflammatory agents.

Claims Coverage

The independent claim specifies 3 inventive features: delivery of a self-supported, wire-like expandable device to an ear region, expansion against tissue from a compressed to an expanded configuration, and biodegradable polymer filaments in a repeating diamond-shaped pattern with drug release. Dependent claims refine these features by adding drug-eluting layers, narrowing the therapeutic agent categories, and adding drug release timing and daily dosage constraints, as well as specific biodegradable polymer composition details.

Ear-region delivery of a self-supported wire-like expandable device

Delivering a self-supported, wire-like expandable device to an ear region of the patient, wherein the expandable device is configured to expand from a first compressed configuration to a second expanded configuration against tissue.

Repeating diamond-shaped biodegradable polymer filament pattern

The expandable device comprises one or more biodegradable polymer filaments formed into a repeating diamond-shaped pattern.

Drug release from the expandable diamond-pattern device

The expandable device is configured to release a drug.

Drug-eluting layer on biodegradable polymer filaments

At least one biodegradable polymer filament is at least partially coated with a drug-eluting layer comprising the drug.

Therapeutic agent categories for the drug

The drug comprises a therapeutic agent selected from specified categories including anti-inflammatory agents.

Drug release over a defined time period

The expandable device releases the drug over a period of time between about 5 days and about 120 days.

Daily dosage limit for drug release

The expandable device releases the drug at a daily dosage of about 500 µg or less per day.

Biodegradable polymer filament material

At least one biodegradable polymer filament comprises poly(lactide-co-glycolide).

Overall claim coverage is anchored by treating a patient using an ear-region, self-supported wire-like expandable device that expands against tissue, uses biodegradable polymer filaments in a repeating diamond-shaped pattern, and is configured to release a drug; dependent claims further specify drug-eluting layers, therapeutic agent categories, release duration, daily dosage limits, and the inclusion of poly(lactide-co-glycolide).

Stated Advantages

Documented Applications

No documented applications found

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.